NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, we went through this before line by line and you said the same things. Do we really need to do this again as if this was not discussed in great detail.

All you’ve done is come up with more suppositions for why it is dead without laying any of it out. That is not how that contract works, and no, it was not terminated. It is an ongoing contractual relationship. Doesn’t set into place the new contract post approval, but it pays out that it continues to exist.

The lack of your seeing something in the financials, that you claim is required to keep it valid, is not the contractual equivalent to saying it is no longer a valid contract. Your statement as a third party has no bearing on whether the contract continues to exist and as I said, if they needed a letter of intent or anything to prove that was the case, that can all be done in complete confidentiality.

Your notion that nothing can be established as fact or contracted with a confidential letter of intent that does not need to be PR’s because it is subject to a major precondition that does not exist at this moment (FDA approval, which is what the FDA would want it to be subject to), is false.

It would not need to be disclosed because it is not yet operational, with a condition precedent pending. But for the purposes of a regulatory process, it is exactly what would be appropriate, especially a regulatory process that needs to remain confidential under FDA rules as well.